Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Management

Group By Ticker
Sort By
Newest | Oldest
Read More
5 minute read
  • Biotech
  • FDA
  • General
  • Management
  • News

Altamira Therapeutics Provides Year-End 2022 Business Update; Promoted Covadonga Pañeda, From Chief Development Officer To Chief Operating Officer

By Benzinga Newsdesk
December 19, 9:51 AM
Altamira Therapeutics Provides Year-End 2022 Business Update Strategic BentrioTM partnering or divestiture process enters decisive phase Partnering or divestiture process for inner ear

CYTO

Read More
3 minute read
  • Management
  • News

STAAR Surgical CEO Caren Mason To Retire; Tom Frinzi Appointed New CEO Effective January 1, 2023

By Benzinga Newsdesk
December 19, 9:16 AM
STAAR Surgical Company (NASDAQ:STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that President and Chief Executive Officer Caren Mason will be retiring December 31,

STAA

Read More
2 minute read
  • Cannabis
  • FDA
  • Legal
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

FDA Green Lights New Study Testing IV Ketamine Infusion For Depressive Disorder

By Lara Goldstein
December 16, 6:03 PM
After a full review of healthcare provider Ehave Inc.'s (OTC Pink: EHVVF) IND application, the U.S.

EHVVF

Read More
2 minute read
  • Cannabis
  • Contracts
  • Earnings
  • Financing
  • Legal
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Awakn Unveils Q3 Results, Touts Revenue Growth, R&D Progress, Commercial Plans

By Lara Goldstein
December 16, 5:54 PM
Psychedelics biotech Awakn Life Sciences Corp. (OTCQB: AWKNF) shared its financial results and business highlights for a three-month period that ended Oct. 31, 2022. Financials showed:

AWKNF

Read More
2 minute read
  • Cannabis
  • Financing
  • Management
  • Markets
  • News
  • Offerings
  • Penny Stocks
  • Psychedelics

Psyence, Revive Therapeutics Ink Private Placements: Capital To Support Drug Trials

By Lara Goldstein
December 16, 5:46 PM
Life sciences biotech Psyence Group Inc. (OTCQB: PSYGF) has closed the second tranche of its previously announced private placement of up to $2.2 million (CA$3 million).

PSYGF

Read More
2 minute read
  • Management
  • News

Bill Pulte Issues Statement On Termination Of PulteGroup COO Brandon Jones

By Michael Horton
December 16, 2:32 PM
The Pulte Family, the founding family of Fortune 500 PulteGroup Inc, issued the following statement following the termination of Brandon Jones, recently named Chief Operating Officer by CEO Ryan Marshall: "Today,

PHM

Read More
2 minute read
  • Management
  • News
  • Penny Stocks
  • Small Cap

TuSimple Named Eric Tapia as CFO

By Charles Gross
December 16, 8:03 AM
TuSimple (NASDAQ: TSP), a global autonomous driving technology company, today announced additional independent appointments to its Board of Directors – including a new Government Security Director, Michael Mosier, and an Audit Committee Chair, Wendy Hayes.

TSP

Read More
4 minute read
  • Management
  • News

Reported Late Thursday, Bionomics Appoints Spyridon “Spyros” Papapetropoulos As President And Chief Executive Officer

By Benzinga Newsdesk
December 16, 1:19 AM
Bionomics Limited (NASDAQ:BNOX, ASX: BNO)))), (Bionomics or the Company) a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of patients

BNOX

Read More
2 minute read
  • Management
  • News
  • Penny Stocks

Eiger BioPharmaceuticals Announced President and CEO David A. Cory Resigned; Dr. David Apelian Named Interim CEO

By Charles Gross
December 15, 6:46 PM
Eiger BioPharmaceuticals, Inc. ("Eiger" or "the company") (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies for hepatitis delta virus (HDV) and other serious diseases, and its Board of Directors today announced that David A.

EIGR

Read More
1 minute read
  • Management
  • News

LDH Growth I Says On Dec. 9, Christopher Cooper Resigned As CEO, CFO, From Board Effective Immediately

By Michael Horton
December 15, 6:15 PM
-SEC Filing

LDHA

Posts pagination

Previous 1 … 283 284 285 … 341 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service